Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Benzonitrile, 4,4'-(fluoro-1h-1,2,4-triazol-1-ylmethylene)bis-
2. Cgp 47645
3. Cgp-47645
1. Cgp 47645
2. 143030-47-1
3. Cgp-47645
4. Rcx0ie6ejz
5. Benzonitrile, 4,4'-(fluoro-1h-1,2,4-triazol-1-ylmethylene)bis-
6. Unii-rcx0ie6ejz
7. Leflutrozole [inn]
8. Leflutrozole [who-dd]
9. Chembl225550
10. Schembl6064562
11. Dtxsid80162296
12. 4-[(4-cyanophenyl)-fluoro-(1,2,4-triazol-1-yl)methyl]benzonitrile
13. Cgp 47,645
14. Q27288053
15. 4,4'-(fluoro-1h-1,2,4-triazol-1-ylmethylene)bisbenzonitrile
Molecular Weight | 303.29 g/mol |
---|---|
Molecular Formula | C17H10FN5 |
XLogP3 | 3 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 3 |
Exact Mass | 303.09202350 g/mol |
Monoisotopic Mass | 303.09202350 g/mol |
Topological Polar Surface Area | 78.3 Ų |
Heavy Atom Count | 23 |
Formal Charge | 0 |
Complexity | 466 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
77
PharmaCompass offers a list of Leflutrozole API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Leflutrozole manufacturer or Leflutrozole supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Leflutrozole manufacturer or Leflutrozole supplier.
PharmaCompass also assists you with knowing the Leflutrozole API Price utilized in the formulation of products. Leflutrozole API Price is not always fixed or binding as the Leflutrozole Price is obtained through a variety of data sources. The Leflutrozole Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Leflutrozole manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Leflutrozole, including repackagers and relabelers. The FDA regulates Leflutrozole manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Leflutrozole API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Leflutrozole supplier is an individual or a company that provides Leflutrozole active pharmaceutical ingredient (API) or Leflutrozole finished formulations upon request. The Leflutrozole suppliers may include Leflutrozole API manufacturers, exporters, distributors and traders.
Leflutrozole Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Leflutrozole GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Leflutrozole GMP manufacturer or Leflutrozole GMP API supplier for your needs.
A Leflutrozole CoA (Certificate of Analysis) is a formal document that attests to Leflutrozole's compliance with Leflutrozole specifications and serves as a tool for batch-level quality control.
Leflutrozole CoA mostly includes findings from lab analyses of a specific batch. For each Leflutrozole CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Leflutrozole may be tested according to a variety of international standards, such as European Pharmacopoeia (Leflutrozole EP), Leflutrozole JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Leflutrozole USP).